Siltuximab: Anti-Human IL-6 Therapeutic Antibody

Siltuximab is a chimeric monoclonal antibody binding to interleukin-6. It's been investigated for the treatment of metastatic renal cell cancer, prostate cancer, and Castleman's disease.